ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,914.40
      -2.29%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.895
      -1.59%
      Bitcoin
      60,525.34
      -5.19%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cynapsus Therapeutics Inc. (MM) (CYNA)

      7. Cynapsus Therapeutics Inc. (MM) (CYNA) News

      CYNA

      Cynapsus Therapeutics Inc. (CYNA)

      Cynapsus Therapeutics Inc. (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CYNA
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      05/04/20228:05AMBusiness WireCyngn Launches Infinitracker – A GPS Asset Tracker and IoT Gateway with 15-year BatteryNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      05/02/20228:05AMBusiness WireCyngn Schedules 2022 First Quarter Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      04/29/20224:20PMBusiness WireCyngn Announces Closing of $20 Million Private Placement Priced At-the-MarketNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      04/28/20229:15AMBusiness WireCyngn Announces Pricing of $20 Million Private Placement Priced At-the-MarketNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      04/21/20228:30AMBusiness WireCyngn Launches DriveMod Kit, a Fully-Equipped Autonomous Vehicle Hardware Integration ModuleNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      03/23/20224:05PMBusiness WireCyngn Reports Fourth Quarter and Year-end 2021 ResultsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      03/14/20228:05AMBusiness WireCyngn Schedules 2021 Fourth Quarter and Year-End Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      02/23/20228:05AMBusiness WireCyngn to Present at the Cowen 2nd Annual Mobility Disruption ConferenceNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      02/15/20228:05AMBusiness WireCyngn Files Patent for DriveMod Kit, an Adaptive, Turnkey Autonomous Vehicle SolutionNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      02/10/20228:05AMBusiness WireCyngn to Present at the Aegis Virtual ConferenceNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      02/03/20228:00AMBusiness WireGreenland Technologies Chooses Cyngn to Bring Autonomous Vehicle Technology to Their Fleet of Lithium-Powered Electric ForkliftsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      01/24/20228:05AMBusiness WireCyngn Announces Appointment of HR Veteran Marc Brown as Vice President of Human ResourcesNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      01/18/20228:05AMBusiness Wire Cyngn and Columbia Vehicle Group to Begin Building Fleet of Autonomous Industrial VehiclesNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      01/10/20228:05AMBusiness WireGlobal Logistics & Fulfillment Taps Cyngn to Bring Autonomous Vehicle Capabilities to its Fulfillment CentersNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      12/08/20218:05AMBusiness WireCyngn to Provide an Insider’s Look into the Company’s Technology Stack in its First Webinar on December 15, 2021NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      11/17/20214:05PMBusiness WireCyngn Reports Third Quarter 2021 ResultsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      11/09/20218:30AMBusiness WireCyngn Schedules 2021 Third Quarter Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      10/22/202112:10PMBusiness WireCyngn Announces Closing of Initial Public OfferingNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      10/19/20215:31PMBusiness WireCyngn Announces Pricing of Initial Public OfferingNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      03/17/20204:23PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      02/15/20177:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      02/03/20174:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      12/08/20165:11PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      11/01/20161:25PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      10/24/20165:00PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      10/21/20165:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      10/21/20165:14PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      10/21/20165:14PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
      10/21/20169:22AMEdgar (US Regulatory)(25-NSE)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
       Showing the most relevant articles for your search:NASDAQ:CYNA